Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: A critical review of the evidence.

Annabel Sheehy, Deborah DAVIS, Caroline S E Homer

Research output: Contribution to journalArticle

11 Citations (Scopus)


The approach to the prevention of early onset GBS disease in the newborn varies considerably from country to country. The Centre for Disease Control in the United States advocates universal culture based screening with the administration of intra-partum antibiotics, usually benzylpenicillin or ampicillin, to women who are colonised with GBS. National groups in the UK and New Zealand advocate a risk-based approach where intra-partum antibiotics are given to women with identified risk factors
Original languageEnglish
Pages (from-to)152-157
Number of pages6
JournalWomen and Birth
Issue number2
Publication statusPublished - 2013


Cite this